Thirty-seven percent (41 of 112) of RA risk loci were found to harbor meQTL variants in CD4+ T and/or B cells in our study, and many of the affected CpGs in turn likely influenced transcriptional activity. Here, CD4 is linked to rheumatoid arthritis.